Syphilis blood test study for at-risk and healthy people
Part of Immune system & allergy, Infections clinical trials.
This study tests two new blood tests for syphilis. It compares them to approved tests using blood from people who may have or had syphilis, including pregnant women, HIV-positive people, and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting tested for syphilis or have had syphilis before.
- You are willing to give one or two extra tubes of blood for the study.
- If you are pregnant or a child under 22, you only give one tube of blood.
- You are 13 or older and can sign a consent form (parents sign for minors).
- You have not taken any antibiotics in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new rapid syphilis test (Multiplo® Complete Syphilis) that can be done at a clinic. It aims to see how well it detects infectious syphilis compared to standard lab tests. You might help if you are getting syphilis testing at the clinic.
This study evaluates a new rapid blood test that checks for HIV, hepatitis B, and syphilis all at once. Researchers want to make sure the test works well, is easy to use, and gives accurate results.
This study tests a new self-test for HIV and syphilis that you can do yourself at a clinic or community site. It is for people who do not know if they have HIV or syphilis and have not tested positive before.
This study tests a new rapid finger-prick test that can check for HIV, hepatitis B, and syphilis at the same time. It aims to see if the test is accurate and easy to use, which could help you get quick results during routine checkups or if you're at risk.
This study is testing a new, faster way to check for syphilis in pregnant people, new mothers, and their newborns, as well as in men and non-pregnant people at a Harris Health clinic. The goal is to make sure more people get the right treatment quickly.
This Phase 3 study tests whether cefixime can treat primary, secondary, or early latent syphilis. It may help by offering another effective antibiotic option, including for some people who also have HIV (if well controlled).
Hear when a new Syphilis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.